🔎 Trials Near Me

መነሻ › የጡንቻ ካንሰር › ሚዙሪ › St. Louis

በSt. Louis፣ MO ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 64 ጥናቶች በSt. Louis እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

The Vanguard Study: Testing a New Way to Screen for Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Washington University School of Medicine, St Louis
እድሜ ከ45 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06995898

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Washington University School of Medicine- Siteman Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06982521

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Mercy Infusion Center - Chippewa, St Louis
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • እና 4 ተጨማሪ
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University, School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06172478

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06369285

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06625775

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University in St Louis, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07222267

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Washington University School of Medicine ( Site 0076), St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine- Siteman Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07007559

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Washington University Siteman Cancer Center ( Site 0031), St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Local Institution - 0140, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • Mercy Health - Sindelar Cancer Center, St Louis
  • Mercy Health - Pratt Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07214532

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine in St. Louis, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213791

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07287098

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Cancer Care Specialists of Illinois, O'Fallon · 16 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Washington Univ. School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07109726

Precision Supplemental Imaging in Women With Dense Breasts

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Washington University School of Medicine, St Louis
እድሜ ከ25 እስከ 55 · ሴቶች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07277738

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Siteman Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05123482

A Phase 1/1b Study of IAM1363 in HER2 Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06253871

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06440005

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University Medical School, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05307705

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Washington University Siteman Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07100106

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Cancer Care Specialists of Central Illinois, O'Fallon · 16 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06790693

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Cancer Care Specialist of Illinois, O'Fallon · 16 ማይል ርቀት
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07211178

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Washington University School of Medicine, St Louis
እድሜ ከ18 እስከ 50 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06904365

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mercy Infusion Center - Chippewa, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital South, St Louis
  • እና 9 ተጨማሪ
እድሜ ከ18 እስከ 60 · ሴቶች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07029399

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • WA Uni School Of Med, St Louis
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT06726148

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine - Siteman Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT07383506

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University, Siteman Cancer Center, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06774963

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital South, St Louis
  • Siteman Cancer Center-South County, St Louis
  • እና 4 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06500481

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT05304962

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Siteman Cancer Center - Washington University Medical Campus, St Louis
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05232916

IDOV-Immune for Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06910657

E-Mindfulness Approaches for Living After Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • Cancer Care Center of O'Fallon, O'Fallon · 16 ማይል ርቀት
እድሜ ከ18 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06748222

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine, St Louis
እድሜ 70 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ27 ጁላይ 2026 · NCT02476786

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine, St Louis
እድሜ ከ18 እስከ 55 · ሴቶች · የተሻሻለው በ27 ጁላይ 2026 · NCT06184750

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Investigative Site #110, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁላይ 2026 · NCT06545942

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT07137416

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Washington University, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT05768139

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

ተሳታዮችን በመፈለግ ላይ
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT04968964

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT05696626

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

ተሳታዮችን በመፈለግ ላይ
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06981208

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Washington University School of Medicine in Saint Louis, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT06757634

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ሜይ 2026 · NCT05972343

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Siteman Cancer Center, St Louis
  • Siteman Cancer Center - North County, Florissant · 13 ማይል ርቀት
  • Memorial Hospital., Shiloh · 17 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • Mercy Hospital Saint Louis, St Louis
  • እና 3 ተጨማሪ
እድሜ ከ50 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2026 · NCT04852887

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT06374459

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT05837455

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • Mercy Hospital Saint Louis, St Louis
  • እና 4 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06418204

Cryoablation vs Lumpectomy in T1 Breast Cancers

ተሳታዮችን በመፈለግ ላይ
  • Washington University School of Medicine, St Louis
እድሜ 50 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ27 ፌብሩ 2026 · NCT05505643

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ፌብሩ 2026 · NCT04354064

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ9 ጃንዩ 2026 · NCT06559540

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ዲሴም 2025 · NCT05977036

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኖቬም 2025 · NCT00353483

WashU DIEP Flap Video and Patient Understanding Improvement

ተሳታዮችን በመፈለግ ላይ
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ኖቬም 2025 · NCT06864754

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, St Louis
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Saint Louis Cancer and Breast Institute-South City, St Louis
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • እና 2 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ኦክቶ 2025 · NCT03418961

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Washington University School of Medicine St. Louis, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2025 · NCT05216432

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Washington University School of Medicine, St Louis
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2025 · NCT03053193

በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች

በSt. Louis ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።